ALA
AMGN icon

Atlas Legacy Advisors’s Amgen AMGN Stock Holding History

Atlas Legacy Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$506K Sell
1,440
-213
-13% -$75.9K 0.09% 129
2025
Q4 		$542K Buy
1,653
+109
+7% +$34.6K 0.09% 133
2025
Q3 		$436K Buy
1,544
+265
+21% +$76.9K 0.08% 136
2025
Q2 		$357K Sell
1,279
-493
-28% -$140K 0.08% 136
2025
Q1 		$552K Buy
1,772
+102
+6% +$30.1K 0.14% 100
2024
Q4 		$435K Buy
+1,670
New +$495K 0.11% 117

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Atlas Legacy Advisors's AMGN Position: Q1 2026 in Review

Atlas Legacy Advisors reduced its Amgen (AMGN) stake by 13% in Q1 2026, selling an estimated $75.9K and leaving 1,440 shares worth $506K. The position accounts for 0.09% of the portfolio, ranked #129.

Atlas Legacy Advisors first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $552K in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Atlas Legacy Advisors held 1,440 shares of Amgen worth $506K as of Q1 2026.
  • Atlas Legacy Advisors sold 213 Amgen shares in Q1 2026, an estimated $75.9K.
  • Amgen made up 0.09% of Atlas Legacy Advisors's portfolio in Q1 2026, its #129 holding.
  • Atlas Legacy Advisors first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • Atlas Legacy Advisors's Amgen position peaked at $552K in Q1 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Atlas Legacy Advisors's 13F filing for Q1 2026, filed 11 May 2026.